RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

Summary

Patients participating in this study will have a diagnosis of Chronic Myeloid Leukemia. This study will evaluate whether the addition of an investigational drug called RAD001 given together with Imatinib will better target leukemia stem cells, causing them to die. Stem cells are a small population of cells, existing primarily within the bone marrow, and are believed to be responsible for the ongoing risk of disease relapse.

Timeline

Start

2013-09

Primary completion

2016-12

Completion

2017-12

Drugs

Indications